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concentrations. These factors (including high uric acid)
have been mentioned in one or more definitions of the
metabolic syndrome [7]. Recently, much attention has
been paid to the metabolic syndrome due to its possible
role as a risk factor for the development of type 2 diabetes
and cardiovascular disease. The worldwide increase in the
prevalence of obesity and diabetes is a reason not only for
the increasing prevalence of the metabolic syndrome but
also of hyperuricaemia.
Hyperinsulinaemia and insulin resistance lead to ele-
vated serum uric acid levels through both direct and indi-
rect mechanisms, which include increased urate produc-
tion as well as decreased renal urate excretion (probably
due to the stimulating effect of insulin on urate reabsorp-
tion in the renal proximal tubule). Hypertension, use of
some drugs (in particular diuretics) and renal disease are
also associated to increased uric acid concentrations.
The link between uric acid and the progression of vascu-
lar disease has been examined not only in epidemiological
studies but also with experimental investigations [8]. The
possible mechanisms involved in this causal relationship are:
- uric acid may induce a thickening of the glomerular
afferent arteriole, activation of the renin-angiotensin
system, and hence hypertension;
- uric acid may contribute to endothelial dysfunction by
inducing anti-proliferative effects on endothelium and
impairing nitric oxide production;
- uric acid stimulates human vascular smooth muscle cell
proliferation and synthesis of C-reactive protein;
- uric acid may increase platelet adhesiveness and
platelet lysis (a platelet dysfunction may be linked to
endothelial dysfunction);
- hyperuricaemia could promote thrombus formation;
- uric acid may have a role in oxidative stress and in the
formation of free radicals;
- uric acid may enhance oxygenation of low-density
lipoprotein cholesterol and lipid peroxidation.
An independent link between uric acid and endothelial
function has been reported in patients with uncomplicated,
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The study by Montalcini et al. reported recently in this
issue of the journal Internal and Emergency Medicine
contributes to originate new concepts about an old topic,
that is uric acid and its role in vascular disease [1]. They
report that in postmenopausal women serum uric acid lev-
els are directly associated with carotid intima-media
thickness independently of other cardiovascular risk fac-
tors (including the metabolic syndrome). The importance
of this finding is due to the fact that an increased carotid
intima-media thickness is a marker of early atherosclero-
sis and may predict cardiovascular events [2].
Several epidemiological studies have reported a posi-
tive association between serum uric acid concentrations
and cardiovascular diseases [3]. In a recent report it has
been concluded that uric acid is a strong risk factor for
both myocardial infarction and stroke [4]. Elevated urate
concentration is significantly and independently associat-
ed with increased risk of future vascular events in diabet-
ic stroke patients [5].
Therefore, it could be useful for physicians to check
for serum uric acid levels for risk stratification.
However, the role of uric acid as an independent risk
factor for cardiovascular events is still debated [6, 7]. In
fact, other confounding factors such as glucose intoler-
ance, obesity, dyslipidaemia, hypertension, use of diuret-
ics and insulin resistance may play a role in determining
the increased vascular risk associated to elevated uric acid
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al cardiovascular risk factors [9].
Renal excretion of urate is regulated by a member of the
organic anion transporter superfamily (URAT1). A specific
expression of URAT1 on human aortic vascular smooth mus-
cle cells has been reported and this could be a mechanism by
which uric acid enters the human vascular smooth muscle
cell, eventually leading to cardiovascular disease [10].
In patients with congestive heart failure an increased pro-
duction of uric acid is mediated by activation of xanthine
oxidase, a producer of uric acid from xanthine and hypoxan-
thine. Xanthine oxidase is also a source of free radicals and
may contribute to oxidative damage in the myocardium. It
has also been reported that a high serum level of uric acid is
an independent predictor of mortality in patients with con-
gestive heart failure [11]. Therefore, xanthine oxidase inhibi-
tion could be a therapeutic strategy for heart failure and it
may be important to measure serum uric acid as a marker of
oxidative stress in patients with congestive heart failure.
Similarly to homocysteine (an amino acid that has been
linked to increased risk of premature coronary artery dis-
ease and stroke), uric acid may have a toxic effect on the
vasculature by inducing clotting abnormalities and oxida-
tive stress. However, lowering of uric acid in patients with
increased vascular risk has not always been accompanied
by prevention of cardiovascular events [12].
In conclusion, a better understanding of the role of uric
acid in health and in disease states may help physicians to
improve their performance in preventing and treating car-
diovascular disease.
References
1.  Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone
F, Pujia A (2007) Relation between serum uric acid and
2
carotid intima-media thickness in healthy postmenopausal
women. Intern Emerg Med 2:19–23
2.  O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke
GL, Wolfson SK Jr (1999) Carotid-artery intima and media
thickness as a risk factor for myocardial infarction and
stroke in older adults. N Engl J Med 340:14–22
3.  Niskanen LK, Laaksonen DE, Nyyssonen K et al (2004)
Uric acid level as a risk factor for cardiovascular and all-
cause mortality in middle-aged men: a prospective cohort
study. Arch Intern Med 164:1546–1551
4.  Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Breteler
MMB (2006) Uric acid is a risk factor for myocardial
infarction and stroke. The Rotterdam study. Stroke
37:1503–1507
5.  Newman EJ, Rahman FS, Lees KR, Weir CJ, Walters MR
(2006) Elevated serum urate concentration independently
predicts poor outcome following stroke in patients with dia-
betes. Diabetes Metab Res Rev 22:79–82
6.  Baker JS, Krishnan E, Chen L, Schumacher HR (2005)
Serum uric acid and cardiovascular disease: Recent devel-
opments, and where do they leave us? Am J Med
118:816–826
7.  Tsoulia SG, Liberopoulosa EN, Mikhailidisb DP, Athyros
VG, Elisa MS (2006) Elevated serum uric acid levels in
metabolic syndrome: an active component or an innocent
bystander? Met Clin Exp 55:1293–1301
8.  Johnson RJ, Kang DH, Feig D et al (2003) Is there a patho-
genetic role for uric acid in hypertension and cardiovascular
and renal disease? Hypertension 41:1183–1190
9.  Zoccali C, Maio R, Mallamaci F, Sesti G, Perticone F
(2006) Uric acid and endothelial dysfunction in essential
hypertension. J Am Soc Nephrol 17:1466–1471
10.  Price KL, Sautin YY, Long DA et al (2006) Human vascu-
lar smooth muscle cells express a urate transporter. J Am
Soc Nephrol 17:1791–1795
11.  Sakai H, Tsutamoto T, Tsutsui T, Tanaka T, Ishikawa C,
Horie M (2006) Serum level of uric acid, partly secreted
from the failing heart, is a prognostic marker in patients
with congestive heart failure. Circ J 70:1006–1011
12.  Simon JA (2006) Clinical trials of uric acid lowering for
coronary heart disease risk reduction. Am J Med 119:e5
E. Manzato: Uric acid